BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35879378)

  • 1. Impact of treatment modalities on prognosis of patients with metastatic renal collecting duct carcinoma.
    Qian X; Wan J; Tan Y; Liu Z; Zhang Y
    Sci Rep; 2022 Jul; 12(1):12678. PubMed ID: 35879378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Treatment Modalities on Prognosis in Patients With Renal Collecting Duct Carcinoma: A Population-Based Study.
    Qian X; Xu J; Liu C; Zhong M; Hong S; Qian C; Zhu J; Zhang J; Wang S
    Front Oncol; 2022; 12():810096. PubMed ID: 35530344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic Outcomes of Cytoreductive Nephrectomy in Synchronous Metastatic Renal-Cell Carcinoma: A Single-Center Experience.
    Choi CI; Kang M; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SIL
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1189-e1199. PubMed ID: 30262447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Site-Specific Metastases and Therapeutic Roles of Surgery and Chemotherapy for Patients With Metastatic Renal Pelvis Cancer: A SEER Based Study.
    Chen WK; Wu ZG; Xiao YB; Wang QQ; Yu DD; Cai J; Zhou CF
    Technol Cancer Res Treat; 2021; 20():15330338211004914. PubMed ID: 33929915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma.
    Xiao R; Liu C; He W; Ma L
    Biomed Res Int; 2021; 2021():6736008. PubMed ID: 34805402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Population Study to Identify Candidates for Cytoreductive Nephrectomy in Patients with Metastatic Sarcomatoid Renal Cell Carcinoma from the Surveillance, Epidemiology, and End Results (SEER) Database.
    Ji B; Li D; Fu S; Zhang Z; Yang T; Wu Y; Zuo Y; Xu Z; Yu N
    Med Sci Monit; 2020 Jun; 26():e921297. PubMed ID: 32516796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytoreductive Partial Nephrectomy versus Cytoreductive Radical Nephrectomy for Locally T
    Xiong SC; Shao YX; Hu X; Yang WX; Dou WC; Li X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 51(4):546-551. PubMed ID: 32691565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collecting duct carcinoma: Epidemiology, clinical characteristics and survival.
    Panunzio A; Tappero S; Hohenhorst L; Cano Garcia C; Piccinelli M; Barletta F; Tian Z; Tafuri A; Briganti A; De Cobelli O; Chun FKH; Tilki D; Terrone C; Kapoor A; Saad F; Shariat SF; Cerruto MA; Antonelli A; Karakiewicz PI
    Urol Oncol; 2023 Feb; 41(2):110.e7-110.e14. PubMed ID: 36456452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics and prognosis of metastatic collecting duct carcinoma.
    Zhou L; Liu Y; Mo J; Cui C; Chi Z; Si L; Kong Y; Yan X; Li S; Wu X; Li J; Xu H; Cao D; Guo J; Sheng X
    Urol Oncol; 2022 Aug; 40(8):385.e1-385.e8. PubMed ID: 35773144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic Patterns and Prognosis of de novo Metastatic Nasopharyngeal Carcinoma in the United States.
    Xu Y; Huang T; Mao M; Zhai J; Chen J
    Laryngoscope; 2021 Apr; 131(4):E1130-E1138. PubMed ID: 32833262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of targeted therapy on management of metastatic renal cell carcinoma: trends in systemic therapy and cytoreductive nephrectomy utilization.
    Psutka SP; Kim SP; Gross CP; Van Houten H; Thompson RH; Abouassaly R; Weight C; Boorjian SA; Leibovich BC; Shah ND
    Urology; 2015 Feb; 85(2):442-50. PubMed ID: 25623717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
    Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
    Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
    Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
    Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience.
    Qi N; Wu P; Chen J; Li T; Ning X; Wang J; Gong K
    World J Surg Oncol; 2017 Jan; 15(1):4. PubMed ID: 28056988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival prognoses of Heng intermediate-risk patients with metastatic renal cell carcinoma treated with immunotherapy or targeted therapy: A real-world, single-center retrospective study.
    Kim SH; Lee DE; Joung JY; Seo HK; Lee KH; Chung J
    Investig Clin Urol; 2020 Mar; 61(2):146-157. PubMed ID: 32158965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Primary Tumor Size on Prognosis in Patients With Metastatic Renal Cell Carcinoma Receiving Cytoreductive Nephrectomy: A Population Study of a Chinese Center and the US SEER Database.
    Jiang W; Shou J; Shi H; Wen L; Zhang H; Zheng S; Li C; Ma J
    Technol Cancer Res Treat; 2021; 20():15330338211019507. PubMed ID: 34032149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
    Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
    Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic nomogram for patients with lung metastatic renal cell carcinoma: a SEER-based study.
    Mao W; Fu Z; Wang K; Wu J; Xu B; Chen M
    Ann Palliat Med; 2021 Mar; 10(3):2791-2804. PubMed ID: 33549017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic Features and Survival Outcomes for Primary Renal Neuroendocrine Neoplasms.
    Yi Z; Liu R; Hu J; He T; Wang Z; Li Y; Zu X
    Clin Genitourin Cancer; 2021 Apr; 19(2):155-161. PubMed ID: 33288452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of different metastatic sites for patients with FIGO stage IVB endometrial cancer after surgery: A SEER database analysis.
    Li H; Zhang R; Chen C; Wu C; Lin H; Li J; Lin Z
    J Surg Oncol; 2020 Oct; 122(5):941-948. PubMed ID: 32682330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.